A study published in JAMA suggests that treatment with vitamin C, in addition to thiamine and hydrocortisone, does not improve treatment outcomes in hospitalized patients with sepsis.
If you are not happy with the results below please do another search
50 search results for:
Mayor Bill de Blasio’s chief medical adviser on Feb. 25 downplayed the results of two studies suggesting that a new coronavirus variant found in New York City in November will be more resistant to vaccines now being administered.
The U.S. Food and Drug Administration on Feb. 25 approved storage and transportation of COVID-19 vaccine developed by Pfizer Inc. and German partner BioNTech SE at standard freezer temperatures for up to two weeks instead of ultra-cold conditions.
Med Ad News talked with Klick Health CEO Lori Grant and new Co-Presidents Greg Rice and Ari Schaefer about the recent appointment of Rice and Schaefer; the introduction of new business units; what clients are seeking from the company; and Klick’s work during the pandemic.
Fishawack Health, a leading commercialization partner for the life science industry, appointed former Covance CEO Deborah Keller as the new Chair of its board.
The U.S. Food and Drug Administration approved AbbVie’s biologic therapy Humira (adalimumab) as a treatment for moderate-to-severe active ulcerative colitis in children aged 5 years and older.
SARS-CoV-2 continues to mutate while spreading around the world – infecting more than 112.7 million people as of Feb. 25, according to the Johns Hopkins University of Medicine Covid-19 Dashboard – as companies such as Pfizer and Moderna evaluate boosters against new variants of the virus.
Shares of Pandion Therapeutics soared more than 131 percent in trading after pharma giant Merck announced the acquisition of the autoimmune-focused company for up to $1.85 billion.
Bahrain approved Johnson & Johnson’s one-dose Covid-19 vaccine for emergency use, the first country to do so, the National Health Regulatory Authority (NHRA) said on Feb. 25.
Regeneron Pharmaceuticals said an independent panel found the company’s Covid-19 antibody cocktail to have “clear clinical efficacy” in reducing the rates of hospitalization and deaths in patients.